Author: itembalabantu
-
A tactile sensor that reads touch straight from colour — no deep learning, but a static, device-level demo
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. A new Science Advances paper (Sasso et al., 3 July 2026) builds a tactile sensor from a stretchable “mechanochromic” film — a soft Bragg reflector that changes structural colour…
-
Two roads to unconventional superconductivity in one week — and why the first question is evidence, not mechanism
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. Two arXiv preprints within days of each other approach superconductivity from opposite ends. One is experimental — a new material (the chiral topological semimetal Ag2Pd3S) reported to be an…
-
Three reactors went critical on deadline — but every one of them was zero-power
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. The US Department of Energy’s Reactor Pilot Program (created by Executive Order 14301) set a target of three advanced reactors reaching criticality by 4 July 2026, using a DOE…
-
How far has noninvasive “brain-to-text” really come? Reading the headlines against the fine print
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not medical or investment advice. The 30-second version What. A study from Meta AI, ENS and the Basque Center on Cognition (Levy et al., Nature Neuroscience, 30 June 2026; “Brain2Qwerty”) reconstructs typed sentences from noninvasive brain…
-
A blood test for Alzheimer’s that predicts when, not just whether — and why 0.945 is the wrong number to quote
Evidence-first notes on bioscience, at the edge of the clinic and the market. Information only — not medical or investment advice. The 30-second version What. A new Nature Medicine study (1 July 2026; Phillips et al., corresponding author C. Cruchaga) reports a 34-marker panel of brain-enriched circular RNAs (circRNAs) measured in blood. Its defensible contribution…
-
Do blood-pressure drugs pay off more the longer you take them? What 51 trials and 357,314 people actually say
Evidence-first notes on bioscience, at the edge of the clinic and the market. Information only — not medical or investment advice. The 30-second version What. A new individual-participant-data meta-analysis in Nature Medicine (1 July 2026) pooled 51 randomized trials and 357,314 people to ask a deceptively simple question: does the relative cardiovascular benefit of blood-pressure…
-
The Demise of the Clinical Research Guru in the AI Era
The rise of AI is fundamentally reshaping the landscape of clinical research, challenging the traditional role of the “guru” or key opinion leader. In an age where vast amounts of public data are accessible to everyone, is the expert opinion still as valuable as it once was? The Democratization of Evidence For decades, the opinions…
-
[Thought] Knowledge Work in the Age of AI
The rise of AI has led to a common prediction: the value of knowledge work is plummeting. With powerful tools that can generate text, summarize information, and write code in seconds, it seems that the days of high-value human expertise are numbered. After all, if an AI can do it, why would anyone pay a…
-
[JUN 10,2025] Today’s trial: CONFIDENCE
P: Adults (≥18 years of age) with CKD and type 2 diabetes (T2D), estimated glomerular filtration rate (eGFR) of 30–90 mL/min/1.73 m2 and UACR of ≥100 to <5000 mg/g. I: EMPA+FINE combo C: Empagliflozin vs Finerenone O: At day 180, the reduction in the UACR with combination therapy was 29% greater than that with finerenone alone (least-squares mean ratio…
-
[Thought] The Rising Cost of Original Training Data: Will Humans Become AI’s Data Providers?
As artificial intelligence (AI) systems evolve, they are becoming increasingly reliant on high-quality, original data to sustain their growth. However, the scarcity and rising cost of obtaining such data are posing significant challenges. A provocative concern is emerging in this context: could humans eventually become mere providers of data, akin to “livestock” for AI systems?…
Uthando Nethemba 